Home  >  Health Check  >  Obesity drug: New hope for weight loss?
Health Check
Obesity drug: New hope for weight loss?
Health Check
Mar 15, 2023

“Diet and exercise” has been the weight-loss mantra for decades but a drug designed for diabetes patients could now offer hope to people who are obese, at a time when researchers are warning that half of the world’s population are expected to be overweight or obese by 2035. One of the first to have injections of Semaglutide in the UK was Jan, who has battled with her weight since childhood. Once the medication took effect she lost four stone and said her hunger disappeared.

Professor Stephen O’Rahilly from the University of Cambridge, explains how the drug mimics our body’s natural appetite signalling but its effects disappear once you stop the weekly injections. Family doctor Margaret McCartney says it might help some who are obese but warns that it has also gained a reputation as a “Hollywood skinny drug", reflecting some of society’s ideas about beauty and celebrity culture.

Presenter: Claudia Hammond Producer: Paula McGrath

(Photo: A jogger running around Clifton Downs, Bristol. Credit: Ben Birchall/PA)

More Episodes



Apr 22, 2026
Making surgery safer for infants

We learn about a new injectable microgel to help reduce bleeding in infants who require surgical care. In a mice model, it reduced bleeding by at least 50%. Ashley Brown, Professor of Biomedical Engineering at North Carolina State University and UNC Chapel Hill tells presenter Claudia Hammond more about this new material her team has designed.

Joined by Professor of Global Health and Epidemiology at Boston University in the US, Dr Matthew Fox, Claudia hears about a mystery illness that is being investigated by health officials in Burundi, which has caused five deaths and sickened thirty-five people. So far lab analysis of the illness - which causes fever, vomiting, and diarrhoea - has been negative for Ebola and Marburg viruses, Rift Valley fever, and others.

We hear about influential analysis from Cochrane which has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.

We’re joined by health journalist Katie Silver in Mexico, who brings us the news that the President, Claudia Sheinbaum, has announced the details of a plan to introduce universal healthcare – no mean feat in country of 130 million people.

And we hear about an experiment that was done by academics to see if they could trick AI chatbots into believing in an entirely fake disease.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Obesity drug: New hope for weight loss?

--:--
--:--